ChiCTR1900021050
尚未开始
/
/
/
2019-01-15
/
/
糖尿病
糖尿病與肩膊功能、肌肉力量、柔韌度及超聲波的評估
糖尿病與肩膊功能、肌肉力量、柔韌度及超聲波的評估
臨床及超聲波評估糖尿病與肩膊功能、肌肉力量、柔韌度
单臂
其它
N/A
N/A
Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong
/
100
/
1990-01-01
1990-01-01
/
1. aged 50 or above; 2. medically diagnosed with Type 2 diabetes; 3. able to sit, stand and walk independently, will be recruited.;
请登录查看1. History of central nervous dysfunction or comorbidities within 6 months (e.g. Heart attack, myocardial infarction, angina, peripheral artery disease, uncontrolled arrhythmias, uncontrolled hypertension, uncontrolled diabetes mellitus, asthmatic exacerbation, COPD exacerbation, active cancer on chemotherapy/radiotherapy, tuberculosis on medication, infectious disease, or any other conditions as declared unfit by a medical officer); 2. Significant musculoskeletal deformity or acute orthopaedics conditions (e.g. Recent fall/repeated falls, recent prolapsed intervertebral disc, severe spinal stenosis, recent joint replacement, severe OA knee(s)/hip(s), obvious limb deformity, presence of arthritis with pain limiting mobility, severe scoliosis, or any other conditions as declared unfit by a medical officer); 3. Neurological conditions (e.g. Stroke, frequent epilepsy, Parkinsonism, gait disturbance, recent head injury, cognitive impairment or any other conditions as declared unfit by a medical officer); 4. History or evidence of vestibular dysfunction; 5. Total blindness/severe visual impairment.;
请登录查看香港中文大學威爾斯親王醫院骨科與創傷學系
/
香港中文大學威爾斯親王醫院骨科與創傷學系的其他临床试验
香港中文大學威爾斯親王醫院骨科與創傷學系的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
